Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of β-human ANP

A. Sugawara, K. Nakao, N. Morii, T. Yamada, Hiroshi Itoh, S. Shiono, Y. Saito, M. Mukoyama, H. Arai, K. Nishimura, K. Obata, H. Yasue, T. Ban, H. Imura

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

To elucidate the synthesis of atrial natriuretic polypeptide (ANP) in the failing heart, 20 human right auricles obtained at cardiovascular surgery were studied. The concentration of α-human ANP-like immunoreactivity (α-hANP-LI) in human right auricles ranged from 13.8 to 593.5 μg/g, and the tissue α-hANP-LI concentration in severe congestive heart failure (CHF) (New York Heart Association [NYHA] functional class III and class IV) (235.4±57.2 μg/g) was much higher than that in mild CHF (NYHA class I and class II) (52.5±15.6 μg/g). Atrial α-hANP-LI levels were significantly correlated with plasma concentrations of α-hANP-LI in these patients (r = 0.84, P < 0.01). High performance gel permeation chromatography and reverse phase high performance liquid chromatography coupled with radioimmunoassay for ANP revealed that the α-hANP-LI in the human auricle consisted of three major components of ANP, γ-human ANP (γ-hANP), β-human ANP (β-hANP) and α-human ANP (α-hANP). Comparing percentages of γ-hANP, β-hANP, and α-hANP in α-hANP-LI in severe CHF with those in mild CHF, the predominant component of α-hANP-LI was γ-hANP in mild CHF, whereas β-hANP and/or α-hANP were prevailing in severe CHF and, especially, β-hANP was markedly increased in human failing hearts. These results demonstrate that the total ANP concentration in the atrium of the human heart is increased in severe CHF and that the increase of ANP in the human failing heart is mainly due to the increase of small molecular weight forms of ANP, β-hANP, and α-hANP, especially β-hANP, and indicate that the processing of ANP precursor, or γ-hANP, in the human failing heart differs from that in the normal heart, suggesting that the failing heart augments synthesis and secretion of ANP as one of its own compensatory responses.

Original languageEnglish
Pages (from-to)1962-1970
Number of pages9
JournalJournal of Clinical Investigation
Volume81
Issue number6
Publication statusPublished - 1988
Externally publishedYes

Fingerprint

Peptides
Heart Failure
Reverse-Phase Chromatography
Heart Atria
Radioimmunoassay
Gel Chromatography
Molecular Weight
High Pressure Liquid Chromatography

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of β-human ANP. / Sugawara, A.; Nakao, K.; Morii, N.; Yamada, T.; Itoh, Hiroshi; Shiono, S.; Saito, Y.; Mukoyama, M.; Arai, H.; Nishimura, K.; Obata, K.; Yasue, H.; Ban, T.; Imura, H.

In: Journal of Clinical Investigation, Vol. 81, No. 6, 1988, p. 1962-1970.

Research output: Contribution to journalArticle

Sugawara, A, Nakao, K, Morii, N, Yamada, T, Itoh, H, Shiono, S, Saito, Y, Mukoyama, M, Arai, H, Nishimura, K, Obata, K, Yasue, H, Ban, T & Imura, H 1988, 'Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of β-human ANP', Journal of Clinical Investigation, vol. 81, no. 6, pp. 1962-1970.
Sugawara, A. ; Nakao, K. ; Morii, N. ; Yamada, T. ; Itoh, Hiroshi ; Shiono, S. ; Saito, Y. ; Mukoyama, M. ; Arai, H. ; Nishimura, K. ; Obata, K. ; Yasue, H. ; Ban, T. ; Imura, H. / Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of β-human ANP. In: Journal of Clinical Investigation. 1988 ; Vol. 81, No. 6. pp. 1962-1970.
@article{730219a632024f6788cddea84ad2d72a,
title = "Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of β-human ANP",
abstract = "To elucidate the synthesis of atrial natriuretic polypeptide (ANP) in the failing heart, 20 human right auricles obtained at cardiovascular surgery were studied. The concentration of α-human ANP-like immunoreactivity (α-hANP-LI) in human right auricles ranged from 13.8 to 593.5 μg/g, and the tissue α-hANP-LI concentration in severe congestive heart failure (CHF) (New York Heart Association [NYHA] functional class III and class IV) (235.4±57.2 μg/g) was much higher than that in mild CHF (NYHA class I and class II) (52.5±15.6 μg/g). Atrial α-hANP-LI levels were significantly correlated with plasma concentrations of α-hANP-LI in these patients (r = 0.84, P < 0.01). High performance gel permeation chromatography and reverse phase high performance liquid chromatography coupled with radioimmunoassay for ANP revealed that the α-hANP-LI in the human auricle consisted of three major components of ANP, γ-human ANP (γ-hANP), β-human ANP (β-hANP) and α-human ANP (α-hANP). Comparing percentages of γ-hANP, β-hANP, and α-hANP in α-hANP-LI in severe CHF with those in mild CHF, the predominant component of α-hANP-LI was γ-hANP in mild CHF, whereas β-hANP and/or α-hANP were prevailing in severe CHF and, especially, β-hANP was markedly increased in human failing hearts. These results demonstrate that the total ANP concentration in the atrium of the human heart is increased in severe CHF and that the increase of ANP in the human failing heart is mainly due to the increase of small molecular weight forms of ANP, β-hANP, and α-hANP, especially β-hANP, and indicate that the processing of ANP precursor, or γ-hANP, in the human failing heart differs from that in the normal heart, suggesting that the failing heart augments synthesis and secretion of ANP as one of its own compensatory responses.",
author = "A. Sugawara and K. Nakao and N. Morii and T. Yamada and Hiroshi Itoh and S. Shiono and Y. Saito and M. Mukoyama and H. Arai and K. Nishimura and K. Obata and H. Yasue and T. Ban and H. Imura",
year = "1988",
language = "English",
volume = "81",
pages = "1962--1970",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "6",

}

TY - JOUR

T1 - Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of β-human ANP

AU - Sugawara, A.

AU - Nakao, K.

AU - Morii, N.

AU - Yamada, T.

AU - Itoh, Hiroshi

AU - Shiono, S.

AU - Saito, Y.

AU - Mukoyama, M.

AU - Arai, H.

AU - Nishimura, K.

AU - Obata, K.

AU - Yasue, H.

AU - Ban, T.

AU - Imura, H.

PY - 1988

Y1 - 1988

N2 - To elucidate the synthesis of atrial natriuretic polypeptide (ANP) in the failing heart, 20 human right auricles obtained at cardiovascular surgery were studied. The concentration of α-human ANP-like immunoreactivity (α-hANP-LI) in human right auricles ranged from 13.8 to 593.5 μg/g, and the tissue α-hANP-LI concentration in severe congestive heart failure (CHF) (New York Heart Association [NYHA] functional class III and class IV) (235.4±57.2 μg/g) was much higher than that in mild CHF (NYHA class I and class II) (52.5±15.6 μg/g). Atrial α-hANP-LI levels were significantly correlated with plasma concentrations of α-hANP-LI in these patients (r = 0.84, P < 0.01). High performance gel permeation chromatography and reverse phase high performance liquid chromatography coupled with radioimmunoassay for ANP revealed that the α-hANP-LI in the human auricle consisted of three major components of ANP, γ-human ANP (γ-hANP), β-human ANP (β-hANP) and α-human ANP (α-hANP). Comparing percentages of γ-hANP, β-hANP, and α-hANP in α-hANP-LI in severe CHF with those in mild CHF, the predominant component of α-hANP-LI was γ-hANP in mild CHF, whereas β-hANP and/or α-hANP were prevailing in severe CHF and, especially, β-hANP was markedly increased in human failing hearts. These results demonstrate that the total ANP concentration in the atrium of the human heart is increased in severe CHF and that the increase of ANP in the human failing heart is mainly due to the increase of small molecular weight forms of ANP, β-hANP, and α-hANP, especially β-hANP, and indicate that the processing of ANP precursor, or γ-hANP, in the human failing heart differs from that in the normal heart, suggesting that the failing heart augments synthesis and secretion of ANP as one of its own compensatory responses.

AB - To elucidate the synthesis of atrial natriuretic polypeptide (ANP) in the failing heart, 20 human right auricles obtained at cardiovascular surgery were studied. The concentration of α-human ANP-like immunoreactivity (α-hANP-LI) in human right auricles ranged from 13.8 to 593.5 μg/g, and the tissue α-hANP-LI concentration in severe congestive heart failure (CHF) (New York Heart Association [NYHA] functional class III and class IV) (235.4±57.2 μg/g) was much higher than that in mild CHF (NYHA class I and class II) (52.5±15.6 μg/g). Atrial α-hANP-LI levels were significantly correlated with plasma concentrations of α-hANP-LI in these patients (r = 0.84, P < 0.01). High performance gel permeation chromatography and reverse phase high performance liquid chromatography coupled with radioimmunoassay for ANP revealed that the α-hANP-LI in the human auricle consisted of three major components of ANP, γ-human ANP (γ-hANP), β-human ANP (β-hANP) and α-human ANP (α-hANP). Comparing percentages of γ-hANP, β-hANP, and α-hANP in α-hANP-LI in severe CHF with those in mild CHF, the predominant component of α-hANP-LI was γ-hANP in mild CHF, whereas β-hANP and/or α-hANP were prevailing in severe CHF and, especially, β-hANP was markedly increased in human failing hearts. These results demonstrate that the total ANP concentration in the atrium of the human heart is increased in severe CHF and that the increase of ANP in the human failing heart is mainly due to the increase of small molecular weight forms of ANP, β-hANP, and α-hANP, especially β-hANP, and indicate that the processing of ANP precursor, or γ-hANP, in the human failing heart differs from that in the normal heart, suggesting that the failing heart augments synthesis and secretion of ANP as one of its own compensatory responses.

UR - http://www.scopus.com/inward/record.url?scp=0023928904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023928904&partnerID=8YFLogxK

M3 - Article

C2 - 2968368

AN - SCOPUS:0023928904

VL - 81

SP - 1962

EP - 1970

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 6

ER -